Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 10123-10137

  Yakimovich, Artur ^a   Gumpert, Heidi ^b,d   Burckhardt, Christoph J ^c   Lütschg, Verena A ^a   Jurgeit, Andreas ^a   Sbalzarini, Ivo F ^a   Greber, Urs F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ADENOVIRUS; ARTICLE; CELL DEATH; CELL STIMULATION; CELL TRANSFER; COMPUTER MODEL; CONTROLLED STUDY; CYTOLYSIS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE DISPLAY; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NONHUMAN; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; VALIDATION PROCESS; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS TRANSMISSION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; BASE SEQUENCE; CELL DEATH; CELL LINE; CELL-FREE SYSTEM; COCULTURE TECHNIQUES; COMPUTER SIMULATION; DIFFUSION; DNA PRIMERS; EPITHELIAL CELLS; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

HUMAN ADENOVIRUS;

EID: 84866173314     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01102-12     Document Type: Article

References (115)

1. Ahmed R, Graham AF. 1977. Persistent infections in L cells with temperature-sensitive mutants of reovirus. J. Virol. 23:250-262.
2. Amstutz B, et al. 2008. Subversion of CtBP1 controlled macropinocytosis by human adenovirus serotype 3. EMBO J. 27:956-966.
3. Bais S, Bartee E, Rahman MM, McFadden G, Cogle CR. 2012. Oncolytic virotherapy for hematological malignancies. Adv. Virol. 2012: 186512.
4. Bankhead A, et al. 2011. A simulation framework to investigate in vitro viral infection dynamics. J. Comput. Sci. doi:10.1016/j.jocs.2011.08.007.
5. Barton KN, et al. 2006. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Mol. Ther. 13: 347-356.
6. Beauchemin C, Samuel J, Tuszynski J. 2005. A simple cellular automaton model for influenza A viral infections. J. Theor. Biol. 232:223-234.
7. Benson SD, Bamford JK, Bamford DH, Burnett RM. 1999. Viral evolution revealed by bacteriophage PRD1 and human adenovirus coat protein structures. Cell 98:825-833.
8. Bergelson JM, et al. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
9. Berk AJ. 2007. Adenoviridae: the viruses and their replication, p 2355-2436. In Knipe DM, Howley PM (ed), Fields virology, 5 ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
10. Berk AJ. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685.
11. Bocharov GA, Romanyukha AA. 1994. Mathematical model of antiviral immune response III. Influenza A virus infection. J. Theor. Biol. 167: 323-360.
12. Bremner KH, et al. 2009. Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6:523-535.
13. Brimacombe CL, et al. 2011. Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J. Virol. 85:596-605.
14. Burckhardt CJ, Greber UF. 2009. Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog. 5:e1000621. doi:10.1371/journal.ppat.1000621.
15. Burckhardt CJ, et al. 2011. Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 10:105-117.
16. Carpenter A, et al. 2006. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7:R100. doi: 10.1186/gb-2006-7-10-r100.
17. Charlotte M, et al. 2001. Light deflection and convection in diffusion experiments using holographic interferometry. J. Phys. D Appl. Phys. 34:3088.
18. Chen EC, et al. 2011. Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a New World monkey colony. PLoS Pathog. 7:e1002155. doi:10.1371/journal.ppat. 1002155.
19. Chen P, Tian J, Kovesdi I, Bruder JT. 1998. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J. Biol. Chem. 273:5815-5820.
20. Chen PH, Ornelles DA, Shenk T. 1993. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67:3507-3514.
21. Clark N, et al. 2011. Stochastic model of virus and defective interfering particle spread across mammalian cells with immune response. arXiv: 1108.4901v1 [q-bio.PE]:1-22. Cornell University Library, Ithaca, NY.
22. Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 86:7590-7594.
23. Davis DM, et al. 2003. The protean immune cell synapse: a supramolecular structure with many functions. Semin. Immunol. 15:317-324.
24. Degond P, Mas-Gallic S. 1989. The weighted particle method for convection-diffusion equations. Part 1: the case of an isotropic viscosity. Math. Comput. 53:485-507.
25. de la Torre JC, Davila M, Sobrino F, Ortin J, Domingo E. 1985. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 145:24-35.
26. Doceul V, Hollinshead M, van der Linden L, Smith GL. 2010. Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327:873-876.
27. Dulbecco R. 1952. Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc. Natl. Acad. Sci. U. S. A. 38:747-752.
28. Einstein A. 1905. Über die von der molekularkinetischen Theorie der Wärme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen. Annalen Phys. 322:549-560.
29. Engelke MF, Burckhardt CJ, Morf MK, Greber UF. 2011. The dynactin complex enhances the speed of microtubule-dependent motions of adenovirus both towards and away from the nucleus. Viruses 3:233-253.
30. Ewers H, et al. 2005. Single-particle tracking of murine polyoma viruslike particles on live cells and artificial membranes. Proc. Natl. Acad. Sci. U. S. A. 102:15110-15115.
31. Fallaux FJ, et al. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
32. Gaggar A, Shayakhmetov DM, Lieber A. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412.
33. Garnett CT, Erdman D, Xu W, Gooding LR. 2002. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 76:10608-10616.
34. Gastaldelli M, et al. 2008. Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 9:2265-2278.
35. Gazzola M, et al. 2009. A stochastic model for microtubule motors describes the in vivo cytoplasmic transport of human adenovirus. PLoS Comp. Biol. 5:e1000623. doi:10.1371/journal.pcbi.1000623.
36. Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WS. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
37. Greber UF, Way M. 2006. A super highway to virus infection. Cell 124:741-754.
38. Greber UF, Webster P, Weber J, Helenius A. 1996. The role of the adenovirus protease on virus entry into cells. EMBO J. 15:1766-1777.
39. Greber UF, Willetts M, Webster P, Helenius A. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486.
40. Green M. 1962. Studies on the biosynthesis of viral DNA. Cold Spring Harbor Symp. Quant. Biol. 27:219-235.
41. Guedan S, et al. 2010. Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth. Mol. Ther. 18:1275-1283.
42. Halliday NL, Tomasek JJ. 1995. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. Exp. Cell Res. 217:109-117.
43. Hausl M, et al. 2010. Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Mol. Ther. 18:1896-1906.
44. Hayashi S, Hogg JC. 2007. Adenovirus infections and lung disease. Curr. Opin. Pharmacol. 7:237-243.
45. Helmuth JA, Burckhardt CJ, Greber UF, Sbalzarini IF. 2009. Shape reconstruction of subcellular structures from live cell fluorescence microscopy images. J. Struct. Biol. 167:1-10.
46. Hilgendorf A, et al. 2003. Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J. Biol. Chem. 278: 51872-51884.
47. Hockney RW, Eastwood JW. 1989. Computer simulation using particles. Taylor & Francis, Bristol, PA.
48. Imelli N, Ruzsics Z, Puntener D, Gastaldelli M, Greber UF. 2009. Genetic reconstitution of the human adenovirus type 2 temperaturesensitive 1 mutant defective in endosomal escape. Virol. J. 6:174.
49. Incropera FP, DeWitt DP. 1990. Fundamentals of heat and mass transfer, 3rd ed. John Wiley & Sons, New York, NY.
50. Karim MFA, Ismail AIM, Ching HB. 2009. Cellular automata modelling of hantarvirus infection. Chaos Solitons Fractals 41:2847-2853.
51. Komarova NL. 2007. Viral reproductive strategies: how can lytic viruses be evolutionarily competitive? J. Theor. Biol. 249:766-784.
52. Krilov LR. 2005. Adenovirus infections in the immunocompromised host. Pediatr. Infect. Dis. J. 24:555-556.
53. Lai SK, Wang YY, Cone R, Wirtz D, Hanes J. 2009. Altering mucus rheology to "solidify" human mucus at the nanoscale. PLoS One 4:e4294. doi:10.1371/journal.pone.0004294.
54. Leopold PL, et al. 2000. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11:151-165.
55. Lewis PF, et al. 2009. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J. Infect. Dis. 199:1427-1434.
56. Li T, Kheifets S, Medellin D, Raizen M. 2010. Measurement of the instantaneous velocity of a Brownian particle. Science 328:1673-1675.
57. Liang M. 2012. Clinical development of oncolytic viruses in China. Curr. Pharm. Biotechnol. 13:1852-1857.
58. Lichtenstein DL, Toth K, Doronin K, Tollefson AE, Wold WS. 2004. Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23:75-111.
59. Lichtenstein DL, Wold WS. 2004. Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission. Cancer Gene Ther. 11: 819-829.
60. Lindert S, Silvestry M, Mullen TM, Nemerow GR, Stewart PL. 2009. Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J. Virol. 83:11491-11501.
61. Liu H, et al. 2010. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329:1038-1043.
62. Loo YM, et al. 2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 103:6001-6006.
63. Lutschg V, Boucke K, Hemmi S, Greber UF. 2011. Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nature Communications, vol 2. Nature Publishing Group. doi:10.1038/ncomms1391.
64. Mallet DG, Heymer K-J, Rank RG, Wilson DP. 2009. Chlamydial infection and spatial ascension of the female genital tract: a novel hybrid cellular automata and continuum mathematical model. FEMS Immunol. Med. Microbiol. 57:173-182.
65. Mangel WF, Baniecki ML, McGrath WJ. 2003. Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin. Cell. Mol. Life Sci. 60:2347-2355.
66. Massanella M, et al. 2009. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells. AIDS 23:183-188.
67. Matsui H, et al. 2006. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. U. S. A. 103:18131-18136.
68. Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D. 2010. Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog. 6:e1000788. doi: 10.1371/journal.ppat.1000788.
69. McGavern DB, Kang SS. 2011. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11:318-329.
70. Meier O, Greber UF. 2003. Adenovirus endocytosis. J. Gene Med. 5:451-462.
71. Metzgar D, et al. 2007. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J. Infect. Dis. 196:1465-1473.
72. Mothes W, Sherer NM, Jin J, Zhong P. 2010. Virus cell-to-cell transmission. J. Virol. 84:8360-8368.
73. Munoz FM, Piedra PA, Demmler GJ. 1998. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin. Infect. Dis. 27:1194-1200.
74. Nakano MY, Greber UF. 2000. Quantitative microscopy of fluorescent adenovirus entry. J. Struct. Biol. 129:57-68.
75. Nilsson EC, et al. 2011. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17:105-109.
76. Othmer HG, Scriven LE. 1971. Instability and dynamic pattern in cellular networks. J. Theor. Biol. 32:507-537.
77. Parks WP, Melnick JL, Rongey R, Mayor HD. 1967. Physical assay and growth cycle studies of a defective adeno-satellite virus. J. Virol. 1:171-180.
78. Pearson JE, Krapivsky P, Perelson AS. 2011. Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput. Biol. 7:e1001058. doi:10.1371/journal.pcbi.1001058.
79. Perelson AS. 2002. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2:28-36.
80. Pesonen S, Kangasniemi L, Hemminki A. 2010. Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data. Mol. Pharm. 8:12-28.
81. Puntener D, et al. 2011. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J. Virol. 85:481-496.
82. Reddy VS, Natchiar SK, Stewart PL, Nemerow GR. 2010. Crystal structure of human adenovirus at 3.5 A resolution. Science 329:1071-1075.
83. Sattentau Q. 2008. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6:815-826.
84. Sauthoff H, et al. 2003. Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum. Gene Ther. 14:425-433.
85. Sbalzarini IF, Hayer A, Helenius A, Koumoutsakos P. 2006. Simulations of (an)isotropic diffusion on curved biological surfaces. Biophys. J. 90:878-885.
86. Sbalzarini IF, Koumoutsakos P. 2005. Feature point tracking and trajectory analysis for video imaging in cell biology. J. Struct. Biol. 151:182-195.
87. Sbalzarini IF, Mezzacasa A, Helenius A, Koumoutsakos P. 2005. Effects of organelle shape on fluorescence recovery after photobleaching. Biophys. J. 89:1482-1492.
88. Scaplehorn N, et al. 2002. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 12:740-745.
89. Schmitz H, Wigand R, Heinrich W. 1983. Worldwide epidemiology of human adenovirus infections. Am. J. Epidemiol. 117:455-466.
90. Scrivano L, Sinzger C, Nitschko H, Koszinowski UH, Adler B. 2011. HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog. 7:e1001256. doi:10.1371/journal.ppat.1001256.
91. Sigal A, et al. 2011. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 477:95-98.
92. Sirena D, et al. 2004. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J. Virol. 78:4454-4462.
93. Slots J. 2010. Human viruses in periodontitis. Periodontol. 2000 53:89-110.
94. Smith E, Breznik J, Lichty BD. 2011. Strategies to enhance viral penetration of solid tumors. Hum. Gene Ther. 22:1053-1060.
95. Smith GL, Law M. 2004. The exit of vaccinia virus from infected cells. Virus Res. 106:189-197.
96. Spector D, Goldman R. 2006. Basic methods in microscopy. Protocols and concepts from cells: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
97. Stafford MA, et al. 2000. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:285-301.
98. Strunze S, et al. 2011. Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe 10:210-223.
99. Suomalainen M, et al. 1999. Microtubule-dependent minus and plus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144:657-672.
100. Tam PE, Messner RP. 1999. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 73:10113-10121.
101. Tang Q, Lundholm-Beauchamp U, Ginsberg HS. 1997. Spontaneous occurrence of early region 1A reiteration mutants of type 5 adenovirus in persistently infected human T-lymphocytes. Virology 230:281-291.
102. Tollefson AE, et al. 1996. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70:2296-2306.
103. Tollefson AE, Scaria A, Saha SK, Wold WS. 1992. The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J. Virol. 66:3633-3642.
104. Tollefson AE, et al. 2001. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J. Virol. 75:8875-8887.
105. Trinh HV, et al. 2012. Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J. Virol. 86: 1623-1637.
106. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF. 2001. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3:1092-1100.
107. van Oostrum J, Burnett RM. 1985. Molecular composition of the adenovirus type 2 virion. J. Virol. 56:439-448.
108. Wang H, et al. 2011. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17:96-104.
109. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. doi:10.1093/nar/gni035.
110. Weisblum Y, et al. 2011. Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J. Virol. 85: 13204-13213.
111. Wennier S, Li S, McFadden G. 2011. Oncolytic virotherapy for pancreatic cancer. Exp. Rev. Mol. Med. 13:e18. doi:10.1017/S1462399411001876.
112. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR. 2005. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79:1992-2000.
113. Wu W, et al. 2011. Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient celltocell spread. J. Virol. 85:10421-10424.
114. Zhang, J, Shakhnovich EI. 2009. Slowly replicating lytic viruses: pseudolysogenic persistence and within-host competition. Phys. Rev. Lett. 102:178103.
115. Zorzenon dos Santos RM, Coutinho S. 2001. Dynamics of HIV infection: a cellular automata approach. Phys. Rev. Lett. 87:168102-168101_168102-168104.